Jakavi 20mg Tablet
Jakavi 20mg Tablet
Ruxolitinib (20mg)
Cheaper alternative availability
Already at the Best Price
This medicine doesn't have a cheaper alternative with the same composition. Our health advisors can help you find other savings options based on your prescription.
About This Medicine
Product description & overview
Jakavi 20mg Tablets: Treating Intermediate to Severe Myelofibrosis
Jakavi 20mg tablets are used to treat intermediate or severe myelofibrosis in adults with a diagnosis of this rare condition. Ruxolitinib, the active ingredient in Jakavi, is an orally administered medication that acts by inhibiting the activity of JAK and TYK protein kinases. These enzymes play a role in inflammation and disease progression associated with myelofibrosis.
Key Features:
* Effective Treatment: Reduces symptoms and improves quality of life for patients with intermediate to severe myelofibrosis.
* Mechanism of Action: Specifically targets JAK and TYK kinase pathways involved in disease processes.
* Dosage: Available in a 20mg tablet form, taken once daily.
Important Information: Jakavi is not intended for use in all individuals with myelofibrosis and may cause side effects like fatigue, nausea, diarrhea, or muscle pain. It's crucial to consult your healthcare provider for personalized dosage recommendations and before taking this medication.
Please remember that this description is for informational purposes only and should not be considered a substitute for medical advice.
Active composition
Ruxolitinib 20 mg
About Ruxolitinib
Ruxolitinib is a kinase inhibitor used to treat myelofibrosis and polycythemia vera. It works by blocking signals that promote cancer cell proliferation. Ruxolitinib is effective in managing hematological malignancies. In summary, Ruxolitinib is beneficial for treating specific blood cancers.
How It Works
Ruxolitinib inhibits Janus kinases (JAK1 and JAK2), reducing signaling pathways that promote cell growth and survival in myeloproliferative disorders.
Dosage & How to Use
Dosage information not available. Please consult your doctor or pharmacist.
Safety Advice
Important precautions
Side Effect Occurrence
Based on clinical trials and patient reports.
Overall Tolerance
Most patients tolerate well
Common Side Effects
Safety Advice
Alcohol
Jakavi 20mg Tablet may be unsafe to use during pregnancy. Although there are limited studies in humans, animal studies have shown harmful effects on the developing baby. Your doctor will weigh the benefits and any potential risks before prescribing it to you. Please consult your doctor.
High Risk
Pregnancy
Jakavi 20mg Tablet is probably unsafe to use during breastfeeding. Limited human data suggests that the drug may pass into the breastmilk and harm the baby.
Medical Advice
Driving
Jakavi 20mg Tablet should be used with caution in patients with kidney disease. Dose adjustment of Jakavi 20mg Tablet may be needed. Please consult your doctor. Use of Jakavi 20mg Tablet is not advised in patients with moderate to severe kidney disease.
Exercise Caution
Breastfeeding
Jakavi 20mg Tablet may decrease alertness, affect your vision or make you feel sleepy and dizzy. Do not drive if these symptoms occur.
Consult Doctor
Kidney
Jakavi 20mg Tablet should be used with caution in patients with liver disease. Dose adjustment of Jakavi 20mg Tablet may be needed. Please consult your doctor.
Regular Checkup
Customer Reviews
0 reviews for Jakavi 20mg Tablet